Business
Australia strikes deal for new Covid pill that could be used in treatment by early 2022 – The Guardian Australia
Molnupiravir has been shown to prevent serious illness and death, although it is still in late stage clinical trials
Australia has secured 300,000 courses of molnupiravir, an antiviral capsule to treat Covid-19 that could be in use by early 2022.
The Morrison government has struck a supply agreement with MSD to provide the oral treatment if it is approved by the Therapeutic…
Continue Reading
-
Business18 hours agoAiming for rock-solid retirement income? I’d buy these two ASX shares
-
Noosa News14 hours agoCharlie the therapy dog reduces stress – Proctor
-
Business17 hours agoWarren Buffett says buy this index fund. It could turn $400 per month into $851,800 with help from Apple, Nvidia, and Tesla.
-
General14 hours agoFour charged over alleged six-hour gang rape of girl in south-west Sydney